In 1964, a 17-year-old student named Randy Gardner set a world record by staying awake for over 11 days as part of a science ...

While our understanding of Alzheimer’s disease is far from complete, the latest therapies, and others in more than 100 ...

Harvard scientists have uncovered that lithium, a naturally occurring element in the brain, may be the missing piece in understanding Alzheimer’s. Their decade-long research shows that lithium ...

Don't assume Alzheimer's only affects the elderly. Learn about early-onset Alzheimer's, its unique symptoms, and how a ...

The FDA mandates MRI screening before the third Leqembi infusion to detect ARIA-E early. ARIA-E can cause brain swelling and has been linked to seizures and deaths. Want to trade this news? Get access ...

Early-onset Alzheimer’s is often more difficult to diagnose and manage due to the relatively young age of the individuals ...

From chestnut to manuka, honey varieties demonstrate neuroprotective power in lab studies against Alzheimer’s disease, but scientists stress that only human trials can reveal real-world benefits.

While amyloid immunotherapy is slowly becoming more accepted in clinical use, its biggest drawback remains the risk of ARIA. Scientists continue to study which patients are most at risk, how to ...

With amyloid immunotherapy in clinical use, scientists need to find better ways to identify the patients most at risk of developing ARIA (see part 16 of this series). One of the biggest danger signs, ...

The first new Alzheimer’s drug approved for use in Australia in 25 years, ticked off by the Therapeutic Goods Association in ...